Position in ZTS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$374,295,531
-$129,150,171 QoQ
Shares Held
3,166,361
-20.9% QoQ
Ownership
0.755%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 97.8911753902982.ToString("F0")%
Shared 2.1088246097017995.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Amundi holds $607,665,967 across 23 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (61.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
3,166,361 | $374,295,531 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
147,599 | $87,523,254 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,765,686 | $53,182,461 | |
| 4 | VTRS |
Viatris Inc
|
3,407,023 | $46,028,880 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
203,637 | $26,827,137 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
78,456 | $5,950,886 | |
| 7 | HCM |
HUTCHMED (China) Ltd
|
232,246 | $3,474,399 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
98,313 | $2,352,630 |
All Filings in ZTS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $374,295,531 | 3,166,361 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $503,445,702 | 4,001,317 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $387,270,409 | 2,646,736 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $428,552,312 | 2,748,011 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $592,020,142 | 3,595,628 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $447,848,777 | 2,748,719 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $367,456,237 | 1,880,726 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $323,618,213 | 1,866,741 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $369,764,961 | 2,185,243 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $408,211,485 | 2,068,255 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $315,150,151 | 1,811,416 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $313,324,205 | 1,819,431 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $300,252,262 | 1,803,967 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $310,049,089 | 2,115,654 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $300,099,511 | 2,023,734 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $263,040,335 | 1,530,283 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $279,862,084 | 1,483,971 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $298,927,956 | 1,224,964 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $316,229,984 | 1,628,876 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $321,789,852 | 1,726,711 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||